ArticleClinicoEconomics and outcomes research : CEOR2019

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain.

Ainhoa Arenaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.